{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T17:31:59Z","timestamp":1791653519727,"version":"4.3.4"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007787","name":"National Research Centre","doi-asserted-by":"publisher","award":["12010113"],"award-info":[{"award-number":["12010113"]}],"id":[{"id":"10.13039\/100007787","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.ejmech.2021.114004","type":"journal-article","created":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T18:49:12Z","timestamp":1637434152000},"page":"114004","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["Application of the dual-tail approach for the design and synthesis of novel Thiopyrimidine\u2013Benzenesulfonamide hybrids as selective carbonic anhydrase inhibitors"],"prefix":"10.1016","volume":"228","author":[{"given":"Heba T.","family":"Abdel-Mohsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed M.","family":"El Kerdawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"Omar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Petreni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasha M.","family":"Allam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoda I.","family":"El Diwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4262-0323","authenticated-orcid":false,"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2021.114004_bib1","first-page":"209","article-title":"Global cancer statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"Ca - Cancer J. Clin."},{"key":"10.1016\/j.ejmech.2021.114004_bib2","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1007\/s00018-019-03351-7","article-title":"Tumor angiogenesis: causes, consequences, challenges and opportunities","volume":"77","author":"Lugano","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ejmech.2021.114004_bib3","series-title":"Tumor Cells and the Onset of Cancer, Molecular Cell Biology","author":"Lodish","year":"2000"},{"key":"10.1016\/j.ejmech.2021.114004_bib4","first-page":"80","article-title":"Tumor hypoxia and malignant progression","volume":"31","author":"Osinsky","year":"2009","journal-title":"Exp. Oncol."},{"key":"10.1016\/j.ejmech.2021.114004_bib5","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0076-6879(04)81023-1","article-title":"Tumor hypoxia and malignant progression","volume":"381","author":"Vaupel","year":"2004","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.ejmech.2021.114004_bib6","doi-asserted-by":"crossref","first-page":"685","DOI":"10.2174\/138161208783877893","article-title":"Cancer-associated carbonic anhydrases and their inhibition","volume":"14","author":"Pastorekova","year":"2008","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.ejmech.2021.114004_bib7","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abj0364","article-title":"Genome-wide synthetic lethal screen unveils novel CAIX-nfs1\/xct axis as a targetable vulnerability in hypoxic solid tumors","volume":"7","author":"Chafe","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ejmech.2021.114004_bib8","doi-asserted-by":"crossref","first-page":"689","DOI":"10.3109\/14756366.2015.1059333","article-title":"A\u00a0magnificent enzyme superfamily: carbonic anhydrases, their purification and characterization","volume":"31","author":"Ozensoy Guler","year":"2016","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.114004_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/metabo8020025","article-title":"Carbonic anhydrases and metabolism","volume":"8","author":"Supuran","year":"2018","journal-title":"Metabolites"},{"key":"10.1016\/j.ejmech.2021.114004_bib10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/978-94-007-7359-2_11","article-title":"Carbonic anhydrase IX: regulation and role in cancer","volume":"75","author":"Benej","year":"2014","journal-title":"Subcell. Biochem."},{"key":"10.1016\/j.ejmech.2021.114004_bib11","doi-asserted-by":"crossref","first-page":"6776","DOI":"10.18632\/oncotarget.2882","article-title":"Carbonic anhydrase XII is a new therapeutic target to overcome chemoresistance in cancer cells","volume":"6","author":"Kopecka","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2021.114004_bib12","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.35176","article-title":"A\u00a0surface proton antenna in carbonic anhydrase ii supports lactate transport in cancer cells","volume":"7","author":"Noor","year":"2018","journal-title":"eLife"},{"key":"10.1016\/j.ejmech.2021.114004_bib13","first-page":"2240","article-title":"The expression of carbonic anhydrase ii in hematological malignancies","volume":"8","author":"Leppilampi","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejmech.2021.114004_bib14","doi-asserted-by":"crossref","first-page":"611","DOI":"10.3892\/ijo.2013.1972","article-title":"A\u00a0potential biomarker by proteomic analysis, exerts significant inhibitory effect on the growth of colorectal cancer cells","volume":"43","author":"Zhou","year":"2013","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ejmech.2021.114004_bib15","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/modpathol.2009.189","article-title":"Carbonic anhydrase ii. A novel biomarker for gastrointestinal stromal tumors","volume":"23","author":"Parkkila","year":"2010","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.ejmech.2021.114004_bib16","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.3390\/cancers12071723","article-title":"The expression of carbonic anhydrases ii, IX and XII in brain tumors","volume":"12","author":"Haapasalo","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.ejmech.2021.114004_bib17","first-page":"3407","article-title":"[clinicopathological significance of the expression of carbonic anhydrase i and ii in human pancreatic cancer]","volume":"92","author":"Sheng","year":"2012","journal-title":"Zhonghua Yixue Zazhi"},{"key":"10.1016\/j.ejmech.2021.114004_bib18","first-page":"5721","article-title":"Association between the expression of carbonic anhydrase ii and clinicopathological features of hepatocellular carcinoma","volume":"17","author":"Zhang","year":"2019","journal-title":"Oncol Lett"},{"key":"10.1016\/j.ejmech.2021.114004_bib19","doi-asserted-by":"crossref","first-page":"84","DOI":"10.18632\/oncotarget.422","article-title":"Recent developments in targeting carbonic anhydrase IX for cancer therapeutics","volume":"3","author":"McDonald","year":"2012","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2021.114004_bib20","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nrd3554","article-title":"Interfering with ph regulation in tumours as a therapeutic strategy","volume":"10","author":"Neri","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2021.114004_bib21","doi-asserted-by":"crossref","first-page":"603","DOI":"10.2147\/JEP.S265620","article-title":"Experimental carbonic anhydrase inhibitors for the treatment of hypoxic tumors","volume":"12","author":"Supuran","year":"2020","journal-title":"J.\u00a0Exp. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.114004_bib22","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/14756366.2015.1122001","article-title":"How many carbonic anhydrase inhibition mechanisms exist?","volume":"31","author":"Supuran","year":"2016","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.114004_bib23","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1021\/cr200176r","article-title":"Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?","volume":"112","author":"Alterio","year":"2012","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2021.114004_bib24","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1021\/cr050262p","article-title":"Carbonic anhydrase as a model for biophysical and physical-organic studies of proteins and protein-ligand binding","volume":"108","author":"Krishnamurthy","year":"2008","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2021.114004_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0163-7258(96)00198-2","article-title":"Structure and mechanism of carbonic anhydrase","volume":"74","author":"Lindskog","year":"1997","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2021.114004_bib26","series-title":"Targeting Carbonic Anhydrases","author":"Supuran","year":"2014"},{"key":"10.1016\/j.ejmech.2021.114004_bib27","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.4155\/fmc.14.68","article-title":"Sulfonamides and their isosters as carbonic anhydrase inhibitors","volume":"6","author":"Carta","year":"2014","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2021.114004_bib28","doi-asserted-by":"crossref","first-page":"6539","DOI":"10.1021\/jm060967z","article-title":"A\u00a0novel class of carbonic anhydrase inhibitors: glycoconjugate benzene sulfonamides prepared by \"click-tailing","volume":"49","author":"Wilkinson","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.114004_bib29","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.bmc.2013.11.016","article-title":"Combining the tail and the ring approaches for obtaining potent and isoform-selective carbonic anhydrase inhibitors: solution and X-ray crystallographic studies","volume":"22","author":"Bozdag","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.114004_bib30","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1021\/jm9900523","article-title":"Carbonic anhydrase inhibitors. Synthesis of water-soluble, topically effective, intraocular pressure-lowering aromatic\/heterocyclic sulfonamides containing cationic or anionic moieties: is the tail more important than the ring?","volume":"42","author":"Scozzafava","year":"1999","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.114004_bib31","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1080\/17460441.2019.1651289","article-title":"Advances in the structural annotation of human carbonic anhydrases and impact on future drug discovery","volume":"14","author":"Nocentini","year":"2019","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.ejmech.2021.114004_bib32","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1021\/jm501798g","article-title":"Carbonic anhydrase inhibitors with dual-tail moieties to match the hydrophobic and hydrophilic halves of the carbonic anhydrase active site","volume":"58","author":"Tanpure","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.114004_bib33","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1021\/jm101541x","article-title":"Ureido-substituted benzenesulfonamides potently inhibit carbonic anhydrase IX and show antimetastatic activity in a model of breast cancer metastasis","volume":"54","author":"Pacchiano","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.114004_bib34","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/COC.0000000000000691","article-title":"A\u00a0phase 1 study of SLC-0111, a novel inhibitor of carbonic anhydrase IX, in patients with advanced solid tumors","volume":"43","author":"McDonald","year":"2020","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.ejmech.2021.114004_bib35","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1021\/cr900028p","article-title":"Enzymology of purine and pyrimidine antimetabolites used in the treatment of cancer","volume":"109","author":"Parker","year":"2009","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2021.114004_bib36","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.2174\/1568026616666160609100410","article-title":"The chemistry and bio-medicinal significance of pyrimidines & condensed pyrimidines","volume":"16","author":"Jain","year":"2016","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.114004_bib37","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/14756360290018602","article-title":"Carbonic anhydrase inhibitors with strong topical antiglaucoma properties incorporating a 4-(2-aminopyrimidin-4-yl-amino)-benzenesulfonamide scaffold","volume":"17","author":"Casini","year":"2002","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.114004_bib38","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1021\/acsmedchemlett.7b00399","article-title":"Discovery of new sulfonamide carbonic anhydrase IX inhibitors incorporating nitrogenous bases","volume":"8","author":"Nocentini","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2021.114004_bib39","doi-asserted-by":"crossref","first-page":"3643","DOI":"10.1016\/j.bmc.2016.06.005","article-title":"Kinetic and X-ray crystallographic investigations of substituted 2-thio-6-oxo-1,6-dihydropyrimidine-benzenesulfonamides acting as carbonic anhydrase inhibitors","volume":"24","author":"Vullo","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.114004_bib40","doi-asserted-by":"crossref","first-page":"112112","DOI":"10.1016\/j.ejmech.2020.112112","article-title":"Inclusion of a 5-fluorouracil moiety in nitrogenous bases derivatives as human carbonic anhydrase IX and XII inhibitors produced a targeted action against MDA-MB-231 and T47D breast cancer cells","volume":"190","author":"Petreni","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.114004_bib41","doi-asserted-by":"crossref","first-page":"115329","DOI":"10.1016\/j.bmc.2020.115329","article-title":"New thiopyrimidine-benzenesulfonamide conjugates as selective carbonic anhydrase ii inhibitors: synthesis, in\u00a0vitro biological evaluation, and molecular docking studies","volume":"28","author":"Abdel-Mohsen","year":"2020","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.114004_bib42","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1071\/CH9881209","article-title":"The chemistry of pyrimidinethiols. Ii. The preparation and reactions of some 2-arenecarbonylmethylthiopyrimidines","volume":"41","author":"Hurst","year":"1988","journal-title":"Aust. J. Chem."},{"key":"10.1016\/j.ejmech.2021.114004_bib43","doi-asserted-by":"crossref","first-page":"17427","DOI":"10.1039\/C6RA28102H","article-title":"Laccase-catalyzed green synthesis and cytotoxic activity of novel pyrimidobenzothiazoles and catechol thioethers","volume":"7","author":"Abdel-Mohsen","year":"2017","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2021.114004_bib44","series-title":"New 2,4-Disubstituted-2-Thiopyrimidines as VEGFR-2 Inhibitors: Design, Synthesis, and Biological Evaluation","author":"Abdel-Mohsen","year":"2019"},{"key":"10.1016\/j.ejmech.2021.114004_bib45","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.ejmech.2019.06.063","article-title":"Novel potent substituted 4-amino-2-thiopyrimidines as dual VEGFR-2 and BRAF kinase inhibitors","volume":"179","author":"Abdel-Mohsen","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.114004_bib46","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1055\/s-1979-28650","article-title":"A\u00a0one-step synthesis of 4-oxo-2-thioxopyrimidine derivatives by the ternary condensation of ethyl cyanoacetate, aldehydes, and thiourea","author":"Kambe","year":"1979","journal-title":"Synthesis"},{"key":"10.1016\/j.ejmech.2021.114004_bib47","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1016\/j.ejmech.2010.02.011","article-title":"Novel benzimidazole-pyrimidine conjugates as potent antitumor agents","volume":"45","author":"Abdel-Mohsen","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.114004_bib48","doi-asserted-by":"crossref","first-page":"7986","DOI":"10.1021\/jo401193e","article-title":"Laccase-catalyzed domino reaction between catechols and 6-substituted 1,2,3,4-tetrahydro-4-oxo-2-thioxo-5-pyrimidinecarbonitriles for the synthesis of pyrimidobenzothiazole derivatives","volume":"78","author":"Abdel-Mohsen","year":"2013","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2021.114004_bib49","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/S0021-9258(18)62326-9","article-title":"The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and c","volume":"246","author":"Khalifah","year":"1971","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2021.114004_bib50","article-title":"Differential expression and function of CAIX and CAXII in breast cancer: a comparison between tumorgraft models and cells","volume":"13","author":"Chen","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2021.114004_bib51","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/sj.bjc.6603530","article-title":"Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer","volume":"96","author":"Hussain","year":"2007","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ejmech.2021.114004_bib52","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/sj.bjc.6601122","article-title":"Carbonic anhydrase-9 expression levels and prognosis in human breast cancer: association with treatment outcome","volume":"89","author":"Span","year":"2003","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ejmech.2021.114004_bib53","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/jnci\/82.13.1107","article-title":"New colorimetric cytotoxicity assay for anticancer-drug screening","volume":"82","author":"Skehan","year":"1990","journal-title":"J.\u00a0Natl. Cancer Inst."},{"key":"10.1016\/j.ejmech.2021.114004_bib54","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0022-5193(68)90188-4","article-title":"Kinetics of pharmacologic response i. Proposed relationships between response and drug concentration in the intact animal and man","volume":"20","author":"Wagner","year":"1968","journal-title":"J.\u00a0Theor. Biol."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421008539?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421008539?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:31:48Z","timestamp":1759329108000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523421008539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":54,"alternative-id":["S0223523421008539"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.114004","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Application of the dual-tail approach for the design and synthesis of novel Thiopyrimidine\u2013Benzenesulfonamide hybrids as selective carbonic anhydrase inhibitors","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.114004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114004"}}